Syngene International Ltd
Syngene International Ltd (SYNGENE) is scheduled to report results on 27 Oct 2026. Syngene International Ltd last reported results for the quarter ended Jun 2026, with sales of ₹736 crore and net profit of ₹-9 crore. The stock last traded at ₹359, a market capitalisation of ₹14,494 crore, on a P/E of 49.0. Over the past 52 weeks the stock has ranged between ₹353 and ₹679. Figures are as of 6 Oct 2026 and are not real time.
Syngene International Ltd share price and key metrics
- Current price
- ₹359
- Market cap
- ₹14,494 cr
- Stock P/E
- 49.0
- Book value
- ₹120
- ROE
- 7.78%
- ROCE
- 9.99%
- Dividend yield
- 0.35%
- 52w high / low
- 679/353
Metrics as of 6 Oct 2026. Not real time.
Track Syngene International Ltd
Cruxal reads every Syngene International Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Syngene International Ltd growth and returns
- 10 Years
- %
- 5 Years
- 11%
- 3 Years
- 5%
- TTM
- -3%
- 10 Years
- %
- 5 Years
- 0%
- 3 Years
- -8%
- TTM
- -42%
- 10 Years
- 4%
- 5 Years
- -10%
- 3 Years
- -23%
- 1 Year
- -44%
- 10 Years
- %
- 5 Years
- 11%
- 3 Years
- 10%
- Last Year
- 8%
Syngene International Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹736 cr, down 15.8% from ₹875 cr a year earlier. Net profit swung to a loss of ₹9 cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 891 | 944 | 1,018 | 875 | 911 | 917 | 1,037 | 736 |
| Expenses | 646 | 660 | 674 | 668 | 711 | 708 | 733 | 645 |
| Operating profit | 245 | 284 | 344 | 206 | 200 | 209 | 303 | 90.8 |
| OPM % | 27.47% | 30.05% | 33.75% | 23.60% | 21.91% | 22.81% | 29.27% | 12.34% |
| Other income | 16.5 | 18.3 | 18.9 | 17.7 | 15.4 | -55.2 | 16.2 | 11.8 |
| Interest | 13.1 | 12.4 | 15.9 | 11.6 | 13.2 | 11.9 | 12.1 | 9.6 |
| Depreciation | 111 | 109 | 106 | 111 | 117 | 114 | 112 | 112 |
| Profit before tax | 137 | 181 | 241 | 101 | 85.2 | 28.4 | 196 | -19.2 |
| Tax % | 22.72% | 27.49% | 23.78% | 14.41% | 21.24% | 47.18% | 24.54% | -53.12% |
| Net profit | 106 | 131 | 183 | 86.7 | 67.1 | 15 | 148 | -9 |
| EPS (₹) | 2.64 | 3.26 | 4.55 | 2.15 | 1.67 | 0.37 | 3.67 | -0.22 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Syngene International Ltd annual results
| ₹ crore | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,423 | 1,826 | 2,012 | 2,184 | 2,604 | 3,193 | 3,489 | 3,642 | 3,739 | 3,600 |
| Operating profit | 474 | 537 | 618 | 678 | 743 | 942 | 1,017 | 1,045 | 921 | 803 |
| OPM % | 33% | 29% | 31% | 31% | 29% | 30% | 29% | 29% | 25% | 22% |
| Net profit | 305 | 332 | 412 | 405 | 396 | 464 | 510 | 496 | 317 | 221 |
| EPS (₹) | 7.64 | 8.29 | 10.30 | 10.12 | 9.88 | 11.57 | 12.69 | 12.33 | 7.86 | 5.49 |
TTM is the trailing twelve months to the most recent quarter.
Syngene International Ltd balance sheet
| ₹ crore | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 200 | 200 | 400 | 400 | 401 | 401 | 402 | 402 | 403 |
| Reserves | 1,520 | 1,768 | 1,776 | 2,421 | 2,897 | 3,217 | 3,856 | 4,324 | 4,436 |
| Borrowings | 787 | 813 | 773 | 893 | 1,022 | 815 | 555 | 578 | 458 |
| Other liabilities | 681 | 922 | 1,214 | 1,169 | 1,245 | 1,398 | 1,339 | 1,491 | 1,757 |
| Total liabilities | 3,189 | 3,704 | 4,163 | 4,883 | 5,564 | 5,831 | 6,152 | 6,796 | 7,055 |
| Fixed assets | 1,030 | 1,377 | 2,020 | 2,201 | 2,393 | 2,667 | 2,850 | 2,802 | 3,000 |
| CWIP | 155 | 274 | 234 | 237 | 346 | 177 | 838 | 1,266 | 1,046 |
| Investments | 158 | 716 | 776 | 702 | 1,034 | 918 | 548 | 647 | 741 |
| Other assets | 1,846 | 1,337 | 1,133 | 1,743 | 1,790 | 2,069 | 1,916 | 2,081 | 2,268 |
| Total assets | 3,189 | 3,704 | 4,163 | 4,883 | 5,564 | 5,831 | 6,152 | 6,796 | 7,055 |
As reported by the company. Total assets equal total liabilities by construction.
Syngene International Ltd cash flow
| ₹ crore | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 446 | 630 | 677 | 701 | 581 | 824 | 1,042 | 1,168 | 915 |
| Cash from investing | -349 | -646 | -424 | -629 | -611 | -653 | -494 | -744 | -839 |
| Cash from financing | -79 | -72 | -226 | 58 | -31 | -342 | -551 | -142 | -215 |
| Net cash flow | 18 | -88 | 28 | 130 | -62 | -172 | -4 | 281 | -138 |
| Free cash flow | 82 | 47 | 34 | 255 | 105 | 305 | 553 | 398 | 547 |
| CFO / operating profit | 111% | 135% | 127% | 116% | 92% | 102% | 115% | 123% | 107% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Syngene International Ltd operating ratios
| Per year | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| ROCE % | — | 17% | 17% | 14% | 13% | 15% | 15% | 13% | 10% |
| Debtor days | 68 | 68 | 72 | 79 | 71 | 61 | 46 | 53 | 50 |
| Inventory days | 82 | 30 | 18 | 41 | 87 | 141 | 94 | 60 | 56 |
| Days payable | 195 | 154 | 156 | 167 | 113 | 109 | 100 | 136 | 138 |
| Cash conversion cycle | -44 | -56 | -66 | -47 | 45 | 92 | 40 | -23 | -32 |
| Working capital days | -48 | -103 | -172 | -66 | -43 | -14 | -27 | -51 | -68 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Syngene International Ltd shareholding pattern
Promoters held 52.59% at Jun 2026, broadly unchanged since Jun 2025. FIIs 11.82% and DIIs 28.01%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 54.72% | 52.74% | 52.74% | 52.68% | 52.68% | 52.68% | 52.68% | 52.59% |
| FIIs | 20.72% | 20.65% | 19.47% | 16.51% | 16.31% | 14.96% | 13.91% | 11.82% |
| DIIs | 17.49% | 19.52% | 21.50% | 24.05% | 24.62% | 25.83% | 26.44% | 28.01% |
| Public | 6.74% | 6.79% | 5.99% | 6.45% | 6.08% | 6.22% | 6.69% | 7.15% |
| No. of shareholders | 1,07,338 | 1,28,806 | 1,25,090 | 1,42,310 | 1,36,061 | 1,31,750 | 1,35,605 | 1,42,277 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is Syngene International Ltd’s next results date?
Syngene International Ltd’s next results are scheduled for 27 Oct 2026.
- Board meetingConsideration and approval of unaudited financial results for Q2 and H1 ending September 30, 2026
See the full results calendar for every Indian company reporting in the next 30 days.
Syngene International Ltd corporate filings
- Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018.Company Updatelow impact
- Syngene International schedules Board meeting on October 27, 2026, to consider and approve unaudited financial results for Q2 FY2027 (ending September 30, 2026)Board Meetinglow impact
Cruxal's analysis: Syngene International Limited has announced a Board meeting scheduled for October 27…
Read the full analysis - Intimation of Closure of Trading WindowInsider Trading / SASTlow impact
- Syngene International Ltd cancels scheduled meeting with analyst/institutional investorsCompany Updatelow impact
Cruxal's analysis: Syngene International has formally intimated the cancellation of a previously scheduled…
Read the full analysis - Syngene International announces resignation of Head of Corporate Affairs and CommunicationsCompany Updatelow impact
Cruxal's analysis: Syngene International Limited has formally disclosed the resignation of Mr. Pramuch Goel…
Read the full analysis - Syngene International schedules analyst/institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Syngene International has issued an intimation regarding a scheduled meeting with…
Read the full analysis - Syngene International schedules analyst and institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Syngene International has announced a scheduled meeting with analysts and institutional…
Read the full analysis - Syngene International Ltd schedules analyst/institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Syngene International Ltd has issued an intimation regarding a scheduled meeting with…
Read the full analysis - Syngene International Limited confirms remittance of final dividend of INR 1.25 per share for FY 2025-26Company Updatelow impact
Cruxal's analysis: Syngene International Limited has issued a formal communication regarding the successful…
Read the full analysis - Syngene International grants Performance Share Units under PSP 2023 planCompany Updatelow impact
Cruxal's analysis: Syngene International has announced the grant of Performance Share Units (PSUs) to…
Read the full analysis - Syngene International to participate in Goldman Sachs Asia Leaders Conference 2026Company Updatelow impact
Cruxal's analysis: Syngene International has announced its participation in the Goldman Sachs Asia Leaders…
Read the full analysis - Syngene International invests INR 2.52 crore in Ampin C&I Power Twelve for captive renewable energy procurementCompany Updatelow impact
Cruxal's analysis: Syngene International Limited has entered into a Share Subscription and Shareholders…
Read the full analysis - Syngene International schedules investor meeting with Entrust Family OfficeCompany Updatelow impact
Cruxal's analysis: Syngene International has announced an investor meeting with Entrust Family Office…
Read the full analysis - Syngene International schedules analyst and institutional investor meetings for August 13-14, 2026Company Updatelow impact
Cruxal's analysis: Syngene International has announced a schedule for meetings with analysts and…
Read the full analysis - Syngene International Limited files transcript for Q1 FY2027 earnings conference callCompany Updatelow impact
Cruxal's analysis: Syngene International Limited has formally submitted the transcript of its Q1 FY2027…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.